Author

N. Dobrovolskaya

Observed names: N Dobrovolskaya, N Yu Dobrovol'skaya, N Yu Dobrovolskaya, N. Y. Dobrovolskaya, N. Yu. Dobrovol'skaya, N. Yu. Dobrovolskaya, N. Yu. Dobrovol’skaya, Natalia Dobrovolskaya, Natalia Yurievna Dobrovolskaya, Natalya Dobrovolskaya

Institution: Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology

Observed institutions: Chang Gung Memorial Hospital, Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology, Elkerliek Ziekenhuis, Curaçao Medical Center, Gdańsk Medical University

ORCID: 0000-0001-9328-4492

Observed ORCID: 0000-0001-9328-4492

OpenAlex ID: A5069200115

A Single-Arm Phase II Trial of First-Line Paclitaxel in Combination with Lapatinib in HER2-Overexpressing Metastatic Breast Cancer

2010 · Agnieszka Jagiello-Gruszfeld, Sergei Tjulandin, et al. · Oncology · 37

A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines

2013 · Mario Campone, Natalya Dobrovolskaya, et al. · The Breast Journal · 20

PDF

Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study

2017 · Guenther G. Steger, Adriana Dominguez, et al. · Clinical Breast Cancer · 12

Lapatinib (L) with weekly paclitaxel (P) as first-line therapy for patients (pts) with HER2+ metastatic breast cancer (MBC).

2009 · A Jagiello-Gruszfeld, S Tjulandin Sergei, et al. · Cancer Research · 4

Phase Ii Study Evaluating Oral Vinorelbine As a Single-Agent As First-Line Chemotherapy for Metastatic Breast Cancer Patients with Bone Metastases (Norbreast-228 Trial): First Efficacy Results

2014 · G.G. Steger, A. Dominguez, et al. · Annals of Oncology · 2

P5-19-01: Final Results of a Three-Arm Randomised Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines.

2011 · M Campone, N Dobrovolskaya, et al. · Cancer Research · 2

5000 A 3-arm randomised phase II study of oral vinorelbine (NVBo) plus capecitabine (X) versus NVBo and X in sequential versus docetaxel (D) plus X in patients with metastatic breast cancer (MBC) previously treated with anthracyclines

2009 · M. Campone, N. Dobrovolskaya, et al. · European Journal of Cancer Supplements · 2

1857 Final results of a phase II study evaluating oral vinorelbine as a single-agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial)

2015 · G.G. Steger, A. Dominguez, et al. · European Journal of Cancer

Long-term use of bevacizumab with interferon-alfa as a first-line targeted therapy of advanced kidney cancer

2015 · A. A. Klimenko, S. A. Ivanov, et al. · Malignant tumours

PDF

Tyrosine kinase inhibitors as a targeted therapy for clear cell renal carcinoma: case report of the intrahepatic bile ducts

2015 · A. D. Kaprin, S. A. Ivanov, et al. · Malignant tumours

PDF

Adjuvant endocrinotherapy of breast cancer (part I)

2014 · N. Yu. Dobrovolskaya, E. K. Vozniy, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Potentialities of adjuvant endocrine therapy for breast cancer (Part II)

2014 · N. Yu. Dobrovolskaya, E. K. Vvoznyi, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

First safety results of an international phase II study evaluating oral vinorelbine as a single agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial).

2014 · Guenther G. Steger, Natalya Dobrovolskaya, et al. · Journal of Clinical Oncology

EP-1060: Dose reduction of postmastectomy radiation in the management of local breast cancer

2013 · Y. Ponkratova, E. Khmelevsky, et al. · Radiotherapy and Oncology

PDF

Peculiarities of development and risk factors of post-mastectomy isolated and disseminated local-regional recurrence

2012 · E. Khmelevsky, Georgiy Panshin, et al.

Sobstvennyy opyt ispol'zovaniya peroral'noy formy vinorelbina

2012 · N. Dobrovolskaya, Н Ю Добровольская, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Dose reduction of postmastectomy irradiation in treatment of locally advanced breast cancer

2012 · E. Khmelevsky, Georgiy Panshin, et al.

Reducing a Postoperative Radiation Dose in the Combined-modality Treatment of Locally Advanced Breast Cancer

2012 · Yu. A. Pankratova, E. V. Khmelevsky, et al. · Russian Journal of Oncology

PDF

Correction of complications in patients with invasive bladder cancer after the combination therapy

2011 · A D Kaprin, N Yu Dobrovolskaya, et al. · Medical academic journal

501 oral OPTIMAL DOSES AND REGIMENS OF DISTANT RADIOTHERAPY IN PATIENTS WITH BONE METASTASES.

2011 · E. Khmelevsky, G. Panshin, et al. · Radiotherapy and Oncology

Dosimetric and Mathematical Monitoring of the Effect of X-Ray Therapy of Cervical Cancer

2009 · R. V. Stavitskii, V. A. Titova, et al. · Biomedical Engineering

Klinicheskie vozmozhnosti ispol'zovaniya tomudeksa v terapii kolorektal'nogo raka

2001 · E K Voznyy, N Yu Dobrovol'skaya, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Izuchenie effektivnosti i bezopasnosti tomudeksa * v 1 - y linii terapii u bol'nykh rasprostranennym kolorektal'nym rakom

2001 · M R Lichinitser, N V Dobrova, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Vozvrashchenie altretamina v praktiku lecheniya bol'nykh s disseminirovannym i retsidivnym rakom yaichnikov

2000 · A. Garin, A. Garin, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Neoplasms of oral cavity and pharynx. Variants of therapy

1996 · N. Dobrovolskaya, Eh.K. Voznyj, et al. · Journal of radiology and nuclear medicine

Works count: 25

Citation count: 79

H-index: 4

I10-index: 3